COLINZ LABORATORIES LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 1.6207 crores during the period ended December 31, 2021 as compared to Rs. 1.9797 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.0856 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.0990 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.15 for the period ended December 31, 2021 as compared to Rs. 0.34 for the period ended September 30, 2021.
Total Income | ₹ 1.6207 crs | ₹1.9797 crs | -18.13% |
Net Profit | ₹0.0856 crs | ₹0.0990 crs | -13.54% |
EPS | ₹0.15 | ₹0.34 | -55.88% |
Financial Results (Q3 FY2022) - YoY Comparison The company has reported total income of Rs. 1.6207 crores during the period ended December 31, 2021 as compared to Rs.1.5273 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0856 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.0297 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.15 for the period ended December 31, 2021 as compared to Rs.0.37 for the period ended December 31, 2020.
Total Income | ₹ 1.6207 crs | ₹1.5273 crs | 6.12% |
Net Profit | ₹0.0856 crs | ₹0.0297 crs | 188.22% |
EPS | ₹0.15 | ₹0.37 | -59.46% |
Financial Results (9 Months Ended FY2022) - YoY Comparison The company has reported total income of Rs.4.6413 crores during the 9 Months period ended December 31, 2021 as compared to Rs.5.4922 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.1461 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.2675 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.89 for the 9 Months period ended December 31, 2021 as compared to Rs.0.78 for the 9 Months period ended December 31, 2020.
Total Income | ₹4.6413 crs | ₹5.4922 crs | -15.49% |
Net Profit | ₹0.1461 crs | ₹0.2675 crs | -45.38% |
EPS | ₹0.89 | ₹0.78 | 14.10% |
Shares of COLINZ LABORATORIES LTD. was last trading in BSE at Rs. 31.70 as compared to the previous close of Rs. 32.00. The total number of shares traded during the day was 4559 in over 76 trades.
The stock hit an intraday high of Rs. 33.60 and intraday low of 30.40. The net turnover during the day was Rs. 146908.00.
Source : Equity Bulls
Keywords
ColinzLaboratories
Q3FY22
9MFY22
ResultUpdate